Investigational Site Number 840002

Cincinnati, Ohio 45267-0542

0 studies enrolling now · 1 studies all time

What they study most

Neoplasm Malignant

Studies at this site

• First in Man Study of SAR566658 Administered in Patients With CA6-Positive and Refractory Solid Tumor — Completed